Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,544,000 | 7,657,000 | 8,906,000 | 15,359,000 | 7,991,000 |
| Marketable Securities | N/A | 810,000 | N/A | N/A | N/A |
| Receivables | 482,000 | 11,046,000 | 497,000 | 8,207,000 | 447,000 |
| Inventories | 23,503,000 | 10,214,000 | 24,501,000 | 9,618,000 | 21,850,000 |
| Other current assets | 635,000 | 307,000 | 138,000 | 3,833,000 | 13,731,000 |
| TOTAL | $30,164,000 | $30,952,000 | $34,042,000 | $37,017,000 | $44,019,000 |
| Non-Current Assets | |||||
| PPE Net | 11,674,000 | 11,511,000 | 11,181,000 | 11,007,000 | 11,352,000 |
| Investments And Advances | N/A | 6,611,000 | N/A | 6,995,000 | N/A |
| Intangibles | 69,086,000 | 67,561,000 | 68,867,000 | 60,714,000 | 63,809,000 |
| Other Non-Current Assets | 17,100,000 | 10,170,000 | 15,704,000 | 9,226,000 | 12,712,000 |
| TOTAL | $97,860,000 | $95,853,000 | $95,752,000 | $87,942,000 | $87,873,000 |
| Total Assets | $128,024,000 | $126,805,000 | $129,794,000 | $124,959,000 | $131,892,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,921,000 | 4,342,000 | 8,202,000 | 7,309,000 | 7,371,000 |
| Accounts payable and accrued liabilities | 22,708,000 | 7,361,000 | 22,000,000 | 7,075,000 | 21,616,000 |
| Other current liabilities | 177,000 | 12,069,000 | 2,000 | 13,699,000 | 2,186,000 |
| TOTAL | $30,008,000 | $28,345,000 | $32,105,000 | $29,059,000 | $32,221,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,298,000 | 14,248,000 | 11,700,000 | 13,200,000 | 11,767,000 |
| Other Non-Current Liabilities | 9,078,000 | 9,035,000 | 8,973,000 | 8,911,000 | 9,434,000 |
| TOTAL | $24,873,000 | $26,750,000 | $24,156,000 | $25,621,000 | $25,253,000 |
| Total Liabilities | $54,881,000 | $55,095,000 | $56,261,000 | $54,680,000 | $57,474,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,197,925 | N/A | N/A | N/A | N/A |
| Common Shares | N/A | 2,439,000 | N/A | 2,456,000 | N/A |
| Other shareholders' equity | 72,808,000 | 70,008,000 | 73,263,000 | 68,516,000 | 74,074,000 |
| TOTAL | $72,808,000 | $71,376,000 | $73,263,000 | $70,008,000 | $74,074,000 |
| Total Liabilities And Equity | $127,689,000 | $126,471,000 | $129,524,000 | $124,688,000 | $131,548,000 |